Hikma Pharmaceuticals Share News (HIK)

MARKET COMMENT: Stocks End Lower While Oil, Gold Prices Rally

BROKER RATINGS SUMMARY: Barclays Likes National Express, Stagecoach

Hikma Pharma to meet investors for potential dollar bond -leads

DUBAI, March 25 (Reuters) - Hikma Pharmaceuticals Plc , a drugs group founded in Jordan in 1978, has picked four banks to arrange a series of fixed income meetings starting Friday for a potential benchmark dollar bond, a document from lead arrangers showed. The company has picked Citigroup,

Hikma Pharmaceuticals Taps Banks To Arrange Bond Issue (ALLISS)

MARKET COMMENT: London Seen Higher; Focus On Greek-German Meeting

MARKET COMMENT: London Seen Higher; Greek Negotiations In Focus

MARKET COMMENT: Resource Stocks Lead Charge As FTSE 100 Breaks 7,000

London close: FTSE 100 books new all-time highs to close above 7000

Dovish central banks and fading worries about Greece exiting the Eurozone propelled the London market to record fresh all-time highs on Friday. At Friday's close, the FTSE 100 index stood strong at 7022.51, up 0.8% on the day, off a touch from its session high of 7024.21. "The FTSE 100's landmark m

FTSE 250 movers: Miners higher, Debenhams weaker on downgrade

Vedanta Resources topped the risers, despite cutting its capital expenditure budget for 2015 by $400m and halving its 2016 budget. Miners Lonmin and Kaz Minerals were making gains on the rising three-month copper futures, which were 1.5% higher. Ophir Energy was boosted as investment analysts at De

Hikma Pharma shares drop on reports of the company's first benchmark bond issuance

Middle East focused Hikma Pharmaceuticals is reportedly planning to sell its first benchmark-sized dollar bonds, according to two people familiar with the sale. Bloomberg News on Tuesday cited sources close to the deal in its report. Shares in Hikma fell 1.8% to 2217p on the back of the report, as m

UK BROKER RATINGS: HSBC Swaps Rio Tinto For Glencore In Super 10 List

UK MORNING BRIEFING: London Starts Week Of Key Market Events Firmly

UK BROKER RATINGS: SocGen Downgrades Sage Group To Sell From Hold

Thursday tips round-up: Hikma Pharmaceuticals, Foxtons

Hikma Pharmaceuticals' decision not to sell its injectables business is probably one of the savviest decisions the company has taken in the last few years. The price-tag mooted was $2bn. More importantly, it put the little-known firm on many investors' radars. That unit saw its sales in the US rise

FTSE 250 movers: Domino Printing up on Japanese acquisition

Japan-based office equipment supplier Brother Industries has agreed to acquire British printing technology company Domino Printing Sciences for £1.03bn, unleashing a 32% surge in the share price. Domino, which has operations in the UK, China, Germany, India, Sweden and the US, will continue to opera